Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 4,881,000 | 4,823,000 | 4,966,000 | 4,982,000 | 5,168,000 |
| Cost of Goods | 2,034,000 | 2,052,000 | 2,064,000 | 2,146,000 | 2,279,000 |
| Gross Profit | 2,847,000 | 2,771,000 | 2,902,000 | 2,836,000 | 2,889,000 |
| Operating Expenses | 2,884,000 | 1,377,000 | 1,955,000 | 1,788,000 | 1,661,000 |
| Operating Income | -37,000 | 1,394,000 | 947,000 | 1,048,000 | 1,228,000 |
| Other Income | 784,000 | -1,085,000 | -320,000 | -500,000 | -348,000 |
| Pre-tax Income | 747,000 | 309,000 | 627,000 | 548,000 | 880,000 |
| Income Tax | 249,000 | 193,000 | 88,000 | 104,000 | 186,000 |
| Net Income Continuous | 498,000 | 116,000 | 539,000 | 444,000 | 694,000 |
| Minority Interests | -2,000 | 13,000 | N/A | -2,000 | 7,000 |
| Net Income | $500,000 | $103,000 | $539,000 | $446,000 | $687,000 |
| EPS Basic Total Ops | 0.56 | 0.12 | 0.64 | 0.52 | 0.80 |
| EPS Basic Continuous Ops | 0.57 | 0.14 | 0.63 | 0.52 | 0.81 |
| EPS Diluted Total Ops | 0.55 | 0.12 | 0.63 | 0.52 | 0.80 |
| EPS Diluted Continuous Ops | 0.57 | 0.13 | 0.63 | 0.52 | 0.81 |
| EBITDA(a) | $298,000 | $1,709,000 | $1,270,000 | $1,383,000 | $1,597,000 |